235 related articles for article (PubMed ID: 30233571)
41. Hypereosinophilic syndrome: case presentation and update.
Leiferman KM; Gleich GJ
J Allergy Clin Immunol; 2004 Jan; 113(1):50-8. PubMed ID: 14713907
[TBL] [Abstract][Full Text] [Related]
42. Hypereosinophilia presenting as eosinophilic vasculitis and multiple peripheral artery occlusions without organ involvement.
Kim SH; Kim TB; Yun YS; Shin JI; Oh IY; Sir JJ; Kim KM; Park HK; Kang HR; Chang YS; Kim YK; Cho SH; Song YW; Choi DC; Min KU; Kim YY
J Korean Med Sci; 2005 Aug; 20(4):677-9. PubMed ID: 16100465
[TBL] [Abstract][Full Text] [Related]
43. Hypereosinophilia.
Bain BJ
Curr Opin Hematol; 2000 Jan; 7(1):21-5. PubMed ID: 10608500
[TBL] [Abstract][Full Text] [Related]
44. Anti-IL-5 and hypereosinophilic syndromes.
Sutton SA; Assa'ad AH; Rothenberg ME
Clin Immunol; 2005 Apr; 115(1):51-60. PubMed ID: 15870021
[TBL] [Abstract][Full Text] [Related]
45. Diversity of clinical manifestations and response to corticosteroids for idiopathic hypereosinophilic syndrome: retrospective study in 33 patients.
Helbig G; Wiśniewska-Piąty K; Francuz T; Dziaczkowska-Suszek J; Kyrcz-Krzemień S
Leuk Lymphoma; 2013 Apr; 54(4):807-11. PubMed ID: 22988896
[TBL] [Abstract][Full Text] [Related]
46. Hypereosinophilic syndromes.
Kahn JE; Blétry O; Guillevin L
Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):863-82. PubMed ID: 19028368
[TBL] [Abstract][Full Text] [Related]
47. Allogeneic peripheral blood stem cell transplantation for hypereosinophilic syndrome with severe cardiac dysfunction.
Chockalingam A; Jalil A; Shadduck RK; Lister J
Bone Marrow Transplant; 1999 May; 23(10):1093-4. PubMed ID: 10373080
[TBL] [Abstract][Full Text] [Related]
48. [Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome].
Pugliese N; Bruzzone M; Della Rossa A; Baldini C; Catarsi E; Tavoni A; D'Ascanio A; Bombardieri S
Reumatismo; 2008; 60(2):120-4. PubMed ID: 18651056
[TBL] [Abstract][Full Text] [Related]
49. Hematologic Malignancies Identified in Patients with Hypereosinophilia and Hypereosinophilic Syndromes.
Jin JJ; Butterfield JH; Weiler CR
J Allergy Clin Immunol Pract; 2015; 3(6):920-5. PubMed ID: 26342744
[TBL] [Abstract][Full Text] [Related]
50. New diagnostic tool for differentiation of idiopathic hypereosinophilic syndrome (HES) and secondary eosinophilic states.
Berki T; Dávid M; Bóné B; Losonczy H; Vass J; Németh P
Pathol Oncol Res; 2001; 7(4):292-7. PubMed ID: 11882909
[TBL] [Abstract][Full Text] [Related]
51. Hypereosinophilic syndrome.
Leiferman KM
Semin Dermatol; 1995 Jun; 14(2):122-8. PubMed ID: 7640191
[TBL] [Abstract][Full Text] [Related]
52. Cardiovascular manifestations of hypereosinophilic syndromes.
Ogbogu PU; Rosing DR; Horne MK
Immunol Allergy Clin North Am; 2007 Aug; 27(3):457-75. PubMed ID: 17868859
[TBL] [Abstract][Full Text] [Related]
53. [Tissue hypereosinophilia].
Desreumaux P; Wallaert B; Janin A
Rev Prat; 2000 Mar; 50(6):630-5. PubMed ID: 10808320
[TBL] [Abstract][Full Text] [Related]
54. A case of T-cell lymphoproliferative disorder associated with hypereosinophilia with excellent response to mycophenolate mofetil.
Hanbali A; Shaheen M; Alfraih F; Al-Otaibi W; El Fakih R; Owaidah T; Ahmed S
Hematol Oncol Stem Cell Ther; 2018 Dec; 11(4):241-244. PubMed ID: 28174010
[TBL] [Abstract][Full Text] [Related]
55. Lymphocytic variant hypereosinophilic syndromes.
Roufosse F; Cogan E; Goldman M
Immunol Allergy Clin North Am; 2007 Aug; 27(3):389-413. PubMed ID: 17868856
[TBL] [Abstract][Full Text] [Related]
56. Pitfalls in the diagnosis of hypereosinophilic syndrome: a report of two cases.
De Vriese AS; Kips JC; Vogelaers DP; Vandewoude KH; Cuvelier CA; Colardyn FA
J Intern Med; 1997 Feb; 241(2):165-70. PubMed ID: 9077374
[TBL] [Abstract][Full Text] [Related]
57. An 8-year-old boy with hypereosinophilic syndrome.
Hosoki K; Nagao M; Iguchi K; Ihara T; Yamada Y; Higashigawa M; Kephart GM; Kita H; Fujisawa T
Int Arch Allergy Immunol; 2011; 155 Suppl 1():117-22. PubMed ID: 21646806
[TBL] [Abstract][Full Text] [Related]
58. Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis.
Nguyen L; Saha A; Kuykendall A; Zhang L
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611061
[TBL] [Abstract][Full Text] [Related]
59. Contemporary Classification and Diagnostic Evaluation of Hypereosinophilia.
Mattis DM; Wang SA; Lu CM
Am J Clin Pathol; 2020 Aug; 154(3):305-318. PubMed ID: 32525541
[TBL] [Abstract][Full Text] [Related]
60. Imatinib Treatment in PDGFRA-Negative Childhood Hypereosinophilic Syndrome.
Weyand AC; Yanik GA; Bailey NG; Wu YM; Mody RJ; Castle VP
Pediatr Blood Cancer; 2016 Jan; 63(1):164-7. PubMed ID: 26257279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
